The correlation between post-operative fentanyl requirements and μ-opioid receptor gene A118G polymorphism in patients undergoing radical gastrectomy

Experimental and Therapeutic Medicine

Volumn 5, Issue 4, 2013, Pages 1147-1152

  Zhang, Fan ^a   Liao, Qin ^a   Li, Li ^a   Wang, Sai Ying ^a   Hu, Rong ^a   Tang, Yong Zhong ^a   Ouyang, Wen ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Analgesia; Fentanyl; Mu opioid receptors; Single nucleotide polymorphism

Indexed keywords

FENTANYL;

ADULT; AGED; ALLELE; ARTICLE; DIZZINESS; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GASTRECTOMY; GENE; GENE FREQUENCY; GENERAL ANESTHESIA; GENOTYPING TECHNIQUE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPRM1 A118G GENE; POLYMERASE CHAIN REACTION; POSTOPERATIVE ANALGESIA; POSTOPERATIVE NAUSEA AND VOMITING; PSYCHOLOGIC ASSESSMENT; RADICAL GASTRECTOMY;

EID: 84874589145     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.955     Document Type: Article

References (28)

1. Ikeda K, Ide S, Han W, Hayashida M, Uhl GR and Sora I: How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol Sci 26: 311-317, 2005.
2. Evans WE and McLeod HL: Pharmacogenomics - Drug disposition, drug targets and side effects. N Engl J Med 348: 538-549, 2003.
3. Weinshilboum R: Inheritance and drug response. N Engl J Med 348: 529-537, 2003.
4. Hu YF, Qiu W, Liu ZQ, Zhu LJ, Liu ZQ, Tu JH, Wang D, Li Z, He J, Zhong GP, Zhou G and Zhou HH: Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation. Clin Exp Pharmacol Physiol 33: 1093-1098, 2006.
5. Walter C and Lötsch J: Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment. Pain 146: 270-275, 2009.
6. Chou WY, Wang CH, Liu PH, Liu CC, Tseng CC and Jawan B: Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology 105: 334-337, 2006.
7. Tan EC, Lim EC, Teo YY, Lim Y, Law HY and Sia AT: Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol Pain 5: 32, 2009.
8. Reyes-Gibby CC, Shete S, Rakvåg T, Bhat SV, Skorpen F, Bruera E, Kaasa S and Klepstad P: Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain 130: 25-30, 2007.
9. Ginosar Y, Davidson EM, Meroz Y, Blotnick S, Shacham M and Caraco Y: Mu-opioid receptor (A118G) single-nucleotide polymorphism affects alfentanil requirements for extracorporeal shock wave lithotripsy: a pharmacokinetic-pharmacodynamic study. Br J Anaesth 103: 420-427, 2009.
10. Klepstad P, Rakvåg TT, Kaasa S, Holthe M, Dale O, Borchgrevink PC, Baar C, Vikan T, Krokan HE and Skorpen F: The 118 A>G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand 48: 1232-1239, 2004.
11. Zhang W, Chang YZ, Kan QC, Zhang LR, Lu H, Chu QJ, Wang ZY, Li ZS and Zhang J: Association of human micro-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients. Anaesthesia 65: 130-135, 2010.
12. Fukuda K, Hayashida M, Ide S, Saita N, Kokita Y, Kasai S, Nishizawa D, Ogai Y, Hasegawa J, Nagashima M, et al: Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery. Pain 147: 194-201, 2009.
13. Fukuda K, Hayashida M, Ikeda K, Koukita Y, Ichinohe T and Kaneko Y: Diversity of opioid requirements for postoperative pain control following oral surgery - is it affected by polymorphism of the μ-opioid receptor? Anesth Prog 57: 145-149, 2010.
14. Hayashida M, Nagashima M, Satoh Y, Katoh R, Tagami M, Ide S, Kasai S, Nishizawa D, Ogai Y, Hasegawa J, et al: Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype. Pharmacogenomics 9: 1605-1616, 2008.
15. Wong CA, McCarthy RJ, Blouin J and Landau R: Observational study of the effect of mu-opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and post-cesarean delivery analgesia. Int J Obstet Anesth 19: 246-253, 2010.
16. Klepstad P, Fladvad T, Skorpen F, Bjordal K, et al: Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain 152: 1139-1145, 2011.
17. Landau R, Kern C, Columb MO, Smiley RM and Blouin JL: Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women. Pain 30: 5-14, 2008.
18. Kasai S: Pharmacogenomics of the human μ-opioid receptor. Pharmacogenomics 12: 1305-1320, 2011.
19. Speilberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA (eds): Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, California, 1983.
20. Zung WW: A self-rating depression scale. Arch Gen Psychiatry 12: 63-70, 1965.
21. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, et al: Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 95: 9608-9613, 1998.
22. Befort K, Filliol D, Decaillot FM, Gaveriaux-Ruff C, Hoehe MR and Kieffer BL: A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem 276: 3130-3137, 2001.
23. Beyer A, Koch T, Schröder H, Schulz S and Höllt V: Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization and resensitization of the human mu-opioid receptor. J Neurochem 89: 553-560, 2004.
24. 2+ channels in humanized mouse sensory neurons. Anesthesiology 115: 1054-1062, 2011.
25. Sia AT, Lim Y, Lim EC, Goh RW, Law HY, Landau R, et al: A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for post-cesarean analgesia. Anesthesiology 109: 520-526, 2008.
26. Zhang W, Yuan JJ, Kan QC, Zhang LR, Chang YZ and Wang ZY: Study of the OPRM1 A118G genetic polymorphism associated with postoperative nausea and vomiting induced by fentanyl intravenous analgesia. Minerva Anestesiol 77: 33-39, 2011.
27. Walldén J, Lindberg G, Sandin M, Thörn SE and Wattwil M: Effects of fentanyl on gastric myoelectrical activity: a possible association with polymorphisms of the mu-opioid receptor gene? Acta Anaesthesiol Scand 52: 708-715, 2008.
28. Lin WQ, Cao LH, Zhong ZJ, Wen LL and Bai XH: Postoperative analgesia with fentanyl combined with flurbiprofen axetil following gynecologic surgery for turnor. Nan Fang Yi Ke Da Xue Xue Bao 29: 313-315, 2009 (In Chinese).